Article detailing how the pharmaceutical industry is leveraging the subject (patient) and care-givers own mobile phone in clinical studies.
- Improving rates and speed of subject/patient recruitment
- Reducing lost to follow up and early withdrawal by as much as 40%
- Aiding protocol compliance using SMS reminders
- Gathering patient reported outcome data (ePRO)
Follow this link to the original article





